Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.825
+0.067 (8.77%)
Dec 20, 2024, 4:00 PM EST - Market closed
Acurx Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -16.44 | -14.58 | -12.09 | -12.75 | -4.6 | -5.93 |
| Stock-Based Compensation | 3.65 | 3.77 | 3.3 | 6.07 | 1.48 | 0.57 |
| Other Operating Activities | 0.47 | - | - | 1.52 | 0.57 | 0.33 |
| Change in Accounts Payable | 0.1 | 0.98 | 1.22 | 0.39 | -0.8 | 1.06 |
| Change in Other Net Operating Assets | -0.11 | 0.03 | 0.03 | -0.25 | -0 | -0.02 |
| Operating Cash Flow | -12.33 | -9.8 | -7.54 | -5.01 | -3.35 | -3.99 |
| Long-Term Debt Issued | - | - | - | - | 0.07 | - |
| Net Debt Issued (Repaid) | - | - | - | - | 0.07 | - |
| Issuance of Common Stock | 11.04 | 8.16 | 3.7 | 14.8 | 3.98 | 4.46 |
| Financing Cash Flow | 11.04 | 8.16 | 3.7 | 14.8 | 4.04 | 4.46 |
| Net Cash Flow | -1.29 | -1.64 | -3.85 | 9.78 | 0.69 | 0.47 |
| Free Cash Flow | -12.33 | -9.8 | -7.54 | -5.01 | -3.35 | -3.99 |
| Free Cash Flow Per Share | -0.80 | -0.77 | -0.70 | -0.59 | -0.54 | -0.84 |
| Levered Free Cash Flow | -6.53 | -4.33 | -3.01 | -0.21 | -2.08 | - |
| Unlevered Free Cash Flow | -6.53 | -4.33 | -3.01 | -0.21 | -2.08 | - |
| Change in Net Working Capital | 0.02 | -1.01 | -1.25 | -0.14 | 1.26 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.